Baroreflex sensitivity in asymptomatic coronary atherosclerosis

Clinical Physiology and Functional Imaging

Volumn 33, Issue 1, 2013, Pages 70-74

  Simula, Sakari ^a   Laitinen, Tomi ^b   Vanninen, Esko ^b   Pajunen, Pia ^c   Syvänne, Mikko ^c   Hedman, Antti ^b   Hartikainen, Juha ^b  

^a Central Hospital   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Asymptomatic; Autonomic nervous system; Baroreflex sensitivity; Coronary artery disease; Parasympathetic nervous system

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PHENYLEPHRINE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MUSCLE ISCHEMIA; MYOCARDIAL DISEASE; PHOTON EMISSION TOMOGRAPHY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; AGED; ASYMPTOMATIC DISEASES; BAROREFLEX; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PHENYLEPHRINE; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REFLEX, ABNORMAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84870787234     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2012.01165.x     Document Type: Article

References (24)

1. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis (2005); 183: 41-47.
2. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwarz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol (2007); 50: 2285-2290.
3. Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, Camm AJ. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J (1992); 67: 129-137.
4. Gidron Y, Kupper N, Kwaijtaal M, Winter J, Denollet J. Vagus-brain communication in atherosclerosis-related inflammation: a neuroimmunomodulation perspective of CAD. Atherosclerosis (2007); 195: e1-e9.
5. Hartikainen J, Mäntysaari M, Mussalo H, Tahvanainen K, Länsimies E, Pyörälä K. Baroreflex sensitivity in men with recent myocardial infarction; impact of age. Eur Heart J (1994); 15: 1512-1519.
6. Hartikainen JE, Tahvanainen KU, Mäntysaari MJ, Tikkanen PE, Länsimies EA, Airaksinen KE. Simultaneous invasive and noninvasive evaluations of baroreflex sensitivity with bolus phenylephrine technique. Am Heart J (1995); 130: 296-301.
7. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichmlmaier AM, Luft FC, Jordan J. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function and blood pressure in hypertensive patients. Hypertension (2010); 55: 619-626.
8. Katsube Y, Saro H, Naka M, Kim BH, Kinoshita N, Koretsune Y, Hori M. Decreased baroreflex sensitivity in patients with stable coronary artery disease is correlated with the severity of coronary narrowing. Am J Cardiol (1996); 78: 1007-1010.
9. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation (1988); 78: 816-824.
10. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet (1998); 351: 478-484.
11. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT Jr, Camm AJ, Schwartz PJ, ATRAMI Investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001); 103: 2072-2077.
12. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol (2008); 13: 191-207.
13. La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol (2009); 53: 193-199.
14. Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Länsimies E. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol (1998); 84: 576-583.
15. Lindgren K, Hagelin E, Hansén N, Lind L. Baroreceptor sensitivity is impaired in elderly subjects with metabolic syndrome and insulin resistance. J Hypertens (2006); 24: 143-150.
16. Pajunen P, Nieminen MS, Taskinen MR, Syvänne M. Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol (1997); 80: 550-556.
17. Pikkujämsä SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, Savolainen MJ, Kesäniemi YA. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens (1998); 11: 523-531.
18. Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, Costa GM. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis (2010); 212: 292-298.
19. Scheffers IJ, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne J, Engeli S, Ceral J, Eckert S, Erglis A, Narkiewicz K, Philipp T, de Leeuw PW. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010); 56: 1254-1258.
20. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation (1988); 78: 969-979.
21. Sevre K, Lefrandt JD, Nordby G, Os I, Mulder M, Gans RO, Rostrup M, Smit AJ. Autonomic function in hypertensive and normotensive subjects: the importance of gender. Hypertension (2001); 37: 1351-1356.
22. Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension (2006); 48: 392-396.
23. Simula S, Vanninen E, Viitanen L, Kareinen A, Lehto S, Pajunen P, Syvänne M, Kuikka J, Laakso M, Hartikainen J. Cardiac adrenergic innervation is affected in asymptomatic subjects with early stage of coronary artery disease. J Nucl Med (2002); 43: 1-7.
24. World Medical Association. World Medical Association Declaration of Helsinki - Ethical principles for medical research involving human subjects. Adopted by the 18th WMA general assembly Helsinki, Finland, June 1964 and amended by the 52nd WMA general assembly, Edinburgh, Scotland, October 2000.